Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function [Phase 2]
A Phase 2 study tested whether 10 mg vardenafil taken twice daily for six weeks affects bladder function in participants with overactive bla…
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition [Phase 4]
Phase 4 clinical trial evaluating transdermal oxybutynin for overactive bladder with a neurological condition has completed and results were…
-
CLINICAL_TRIALS trial_result · 2009-12-21Clinical Trial Update: Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder [Phase 2]
Phase 2 study evaluating tolterodine, pregabalin, and a tolterodine-pregabalin combination for treating overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2009-10-28Clinical Trial Update: Ultrasonographic Bladder Wall Thickness and Different Forms of Detrusor Overactivity
This completed clinical trial from Università degli Studi dell'Insubria examined ultrasonographic bladder wall thickness across different fo…
-
CLINICAL_TRIALS trial_result · 2009-09-17Clinical Trial Update: 516-BOTOX Urinary Incontinence Detrusor
This clinical trial update reports the completion of a study evaluating BOTOX (onabotulinumtoxinA) for urinary incontinence associated with …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: Fesoterodine Flexible Dose Study [Phase 3]
Phase 3 study of fesoterodine with flexible dosing in adults with overactive bladder completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: A Phase II Study of KUC-7483 in Patients With Overactive Bladder [Phase 2]
Phase II study of KUC-7483 in overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-03Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) [Phase 3]
Phase 3 trial comparing fesoterodine with tolterodine evaluated efficacy and safety in overactive bladder. Results were posted following com…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating intravesical instillation of botulinum toxin type A for urge urinary incontinence.
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Microorganism in Overactive Bladder Patients [Phase 4]
Phase 4 clinical trial evaluating a microorganism therapy for overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-18Clinical Trial Update: Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms [Phase 2]
A Phase 2 dose-ranging trial comparing solabegron to placebo in women with overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-15Clinical Trial Update: Urinary Urgency Outcomes Following Propiverine Treatment for an Overactive Bladder [Phase 4]
Phase 4 clinical trial update reporting urinary urgency outcomes after treatment with propiverine in patients with Overactive bladder.
-
FDA approval · 2009-04-08FDA Approved: TOLTERODINE TARTRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tolterodine tartrate filed by Mylan Pharmaceuticals Inc. under NDA 020771.
-
CLINICAL_TRIALS trial_result · 2009-02-10Clinical Trial Update: A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients [Phase 3]
Phase 3 clinical trial assessing fesoterodine for treatment satisfaction and symptom improvement in overactive bladder; completed with resul…
-
CLINICAL_TRIALS research · 2009-02-10Clinical Trial Update: Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding [NA]
This document reports a clinical trial comparing cystoscopy plus urethral dilatation to cystoscopy alone in women with overactive bladder an…
-
FDA approval · 2009-02-04FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original application for oxybutynin chloride, enabling a generic option for treating overactive bladder…
-
CLINICAL_TRIALS trial_result · 2009-01-22Clinical Trial Update: Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP) [Phase 4]
Phase 4 clinical trial evaluating solifenacin for overactive bladder symptoms in patients who have undergone GreenLight PVP surgery.
-
FDA approval · 2009-01-06FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith Laboratories' supplemental application for oxybutynin chloride. This action confirms approval of changes to the ge…
-
FDA approval · 2009-01-06FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved the supplemental application for oxybutynin chloride submitted by Strides Pharma Science Limited. The approval covers changes a…
-
CLINICAL_TRIALS trial_result · 2008-12-25Clinical Trial Update: A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031 [Phase 1]
This Phase 1 trial is a randomized, double-blind, placebo-controlled two-way crossover study to assess the safety and tolerability of a sing…
-
CLINICAL_TRIALS research · 2008-12-16Clinical Trial Update: Non-Micturation Bladder Activity in Relation to Self-Consciousness During Filling Phase and Sensation Measurement During the Filling Phase
Clinical trial from Maastricht University Medical Center examining non-micturation bladder activity and sensation during the filling phase i…
-
CLINICAL_TRIALS trial_result · 2008-11-24Clinical Trial Update: Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome [Phase 3]
Long-term open-label extension study for subjects completing a Phase 3 trial of fesoterodine for overactive bladder (Phase 3).
-
CLINICAL_TRIALS trial_result · 2008-11-24Clinical Trial Update: Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome [Phase 3]
Pfizer reports the completion of a long-term open-label extension study for fesoterodine (SP584) in subjects who completed the Phase 3 trial…
-
CLINICAL_TRIALS trial_result · 2008-11-21Clinical Trial Update: Dose-Escalating Study of Propiverine Hydrochloride in Children Suffering From Overactive Bladder [Phase 2]
Completed Phase 2 dose-escalation trial evaluating propiverine hydrochloride in children with overactive bladder.
-
FDA label_change · 2008-11-18FDA Approved: VESICARE — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for Vesicare (solifenacin succinate) from Astellas Pharma US, Inc., resulting in changes to the prod…